Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin for radiation-induced rectal injury in prostate cancer
NCT00580970Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Apr 2007
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lovastatin in radiation-induced rectal injury, sponsored by Virginia Commonwealth University. Started Apr 2007; status: completed.
02
Drugs
lovastatin
03
Conditions
radiation-induced rectal injury
Beyond the preview
Go deeper on NCT00580970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00580970.